Digital Medicine that measures medication treatment effectiveness and helps physicians improve clinical outcomes was developed by Proteus Digital Health. Armed with more than 450 issued patents and led by some of the brightest minds in technology, pharmaceuticals and healthcare, the company has invented Digital Medicine, a new category of pharmaceuticals. Together, with leading health systems and pharmaceutical companies, the company is bringing this new digital solution to healthcare providers, thereby increasing access to better insight, optimized therapies and lower costs. The executive team and board of directors guide Proteus based on their depth of expertise across life sciences, consumer technology and capital markets.

Proteus Discover is comprised of ingestible sensors, a small wearable sensor patch, an application on a mobile device and a provider portal. Once activated, Proteus Discover unlocks never-before-seen insight into patient health patterns and medication treatment effectiveness, leading to more informed healthcare decisions for everyone involved. With Proteus Discover, patients can easily monitor their medication-taking patterns on their mobile device. Physicians have access to objective data that enables them to initiate, titrate, eliminate medication. Health systems are able to measure treatment effectiveness and optimize therapies.

Proteus Discover provides the tools and data needed for health organizations to build patient engagement, efficiency, and measurement into the delivery of care, and an opportunity to mitigate the high costs of uncontrolled diseases. Proteus Discover can make the biggest impact with high-risk populations, including patients with hypertension and diabetes (lat. Diabetes Mellitus). In a recent study, patients with uncontrolled hypertension and diabetes, who used Proteus Discover achieved a significantly greater reduction in blood pressure and LDL cholesterol and were more likely to reach their blood pressure goal than usual care without Proteus Discover.

Proteus Discover consists of an ingestible sensor the size of a grain of sand, a small wearable sensor patch, an application on a mobile device and a provider portal. The patient activates Proteus Discover by taking medication with an ingestible sensor. Once the ingestible sensor reaches the stomach, it transmits a signal to the patch worn on the torso. A digital record is sent to the patient's mobile device and then to the Proteus cloud where with the patient's permission, healthcare providers and caregivers can access it via their portal. The patch also measures and shares patient activities and rest.

Proteus Digital Health has raised $50 million from undisclosed investors. The company’s existing investors include Medtronic, Itochu, St. Jude Medical, and Kaiser Permanente Ventures. This brings the company’s total funding to at least $450 million.